Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings?

Royalty Pharma has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 31.5% and now trades at $45.91. This performance may have investors wondering how to approach the situation.